Skip to Main Content

Podcast Archive

HelixTalk Episode #10 - Pet Peeves

Date posted: August 12, 2014, 6:00 am

In this episode, we discuss our clinical "pet peeves" covering allergy histories, creatinine clearance, surrogate endpoints, "me too" enantiomer drugs, and dose-dependent pharmacology of psychiatric medications.


HelixTalk Episode #9 - Combining ACE-I, ARB, and DRIs

Date posted: July 29, 2014, 6:00 am

In this episode, we discuss the pharmacology of the renin-angiotensin-aldosterone system and review the evidence for combining ACE-Is, ARBs, and/or DRIs.


HelixTalk Episode #8 - HCAP, HAP, and VAP

Date posted: July 15, 2014, 6:00 am

In this episode, we discuss the 2005 ATS/IDSA Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia Guidelines (HCAP, HAP, VAP).


HelixTalk Episode #7 - Community-Acquired Pneumonia Guidelines

Date posted: July 1, 2014, 6:00 am

In this episode, we discuss the 2007 ATS/IDSA Community-Acquired Pneumonia (CAP) guidelines.


HelixTalk Episode #6 - Updates to GOLD Guidelines and COPD

Date posted: June 17, 2014, 6:00 am

In this episode, we discuss updates to the GOLD guidelines for COPD and review the newer agents for COPD including roflumilast (Daliresp), indacaterol (Arcapta Neohaler), aclidinium (Tudorza Pressair), umeclidinium/vilanterol (Anoro Ellipta), and fluticasone/vilanterol (Breo Ellipta).


HelixTalk Episode #5 - Smoking Cessation

Date posted: June 3, 2014, 6:00 am

In this episode, we discuss smoking cessation, including nicotine replacement therapy, bupropion (Zyban), and varenicline (Chantix).


HelixTalk Episode #4 - P2Y12 Inhibitors, DAPT, and TOAT

Date posted: May 20, 2014, 6:00 am

In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT).


HelixTalk Episode #3 - Novel Oral Anticoagulants (NOACs)

Date posted: May 6, 2014, 6:00 am

In this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis).


HelixTalk Episode #2 - Antihypertension Guidelines (JNC 8 and more)

Date posted: April 22, 2014, 6:00 am

In this episode, we discuss the new JNC 8 guidelines and how these guidelines differ from other hypertension guidelines released in 2013-2014.


HelixTalk Episode #1 - 2013 ACC/AHA Lipid Guidelines

Date posted: April 8, 2014, 6:00 am

In this episode, we discuss the new, rebranded podcast (HelixTalk) and review the new ACC/AHA 2013 lipid guidelines.